EstroPause
- St. John's WortCategory D
LiverTox Category D. Few case reports of hepatitis; causality uncertain. Major drug-interaction concern (CYP3A4 induction) — can reduce levels of warfarin, oral contraceptives, immunosuppressants, HIV antivirals.
LiverTox →
Supplement Facts
10 active ingredients| Ingredient | Amount | % DV |
|---|---|---|
| Calcium UNII · SY7Q814VUP | 500 mg | 50% |
| Magnesium UNII · I38ZP9992A | 200 mg | 50% |
| Fish Oil UNII · XGF7L72M0F | 2158 mg | — |
| St. John's Wort extract St. John's WortUNII · UFH8805FKA | 300 mg | — |
| Soy Isoflavones isoflavone (unspecified)UNII · 71B37NR06D | 100 mg | — |
| Black cohosh extract Black CohoshUNII · K73E24S6X9 | 80 mg | — |
| Red clover powder Red CloverUNII · L9153EKV2Y | 40 mg | — |
| Asian Ginseng extract Oriental Ginseng | 31 mg | — |
| Chaste Tree Extract ChastetreeUNII · 433OSF3U8A | 20 mg | — |
| BioPerine Complex Proprietary Blend | 6 mg | — |
1 flagged · authority citations
- ● AVOIDTitanium Dioxidecolor
Banned in EU food products effective 2022-08 (Commission Regulation (EU) 2022/63) following EFSA Panel opinion that a safe daily intake could not be established due to genotoxicity concerns. Still GRAS in the US under 21 CFR 73.575 but EU position is stricter.
CAERS reports are unverified consumer submissions — not adjudicated causality. Large well-known brands accumulate proportionally more reports simply due to broader use. About CAERS →
Gelatin · purified Water · Glycerin · Soy Lecithin · Beeswax · Lycopene
Same formula, different brand
Products with identical sorted (ingredient, amount) tuples.